Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-10-03 Sale | 2022-10-05 4:24 pm | MAXCYTE Inc | MXCT | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner | 735,786 | $6.15 | $4,525,084 | 10,000,000 (Direct) | View |
2022-07-01 Sale | 2022-07-06 5:01 pm | MAXCYTE Inc | MXCT | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner | 3,235,548 | $4.3 | $13,912,856 | 10,735,786 (Direct) | View |
2021-08-03 Purchase | 2021-08-04 6:33 pm | Tenaya Therapeutics Inc. | TNYA | Casdin Partners Master Fund L.P. Casdin Private Growth Equity Fund L.P. Casdin Capital LLC CASDIN PRIVATE GROWTH EQUITY FUND GP LLC 10% Owner | 850,000 | $15 | $12,750,000 | 361,969 (Indirect) | View |
2021-07-30 Purchase | 2021-08-03 6:08 pm | MAXCYTE Inc | MXCT | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner | 1,800,000 | $13 | $23,400,000 | 13,971,334 (Direct) | View |
2021-07-26 Purchase | 2021-07-28 4:33 pm | Absci Corp | ABSI | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Private Growth Equity Fund L.P. CASDIN PRIVATE GROWTH EQUITY FUND GP LLC Director | 1,562,500 | $16 | $25,000,000 | 7,718,593 (Indirect Direct) | View |
2021-06-21 Purchase | 2021-06-22 5:12 pm | Verve Therapeutics Inc. | VERV | Casdin Partners Master Fund L.P. 10% Owner | 1,100,000 | $19 | $20,900,000 | 2,417,596 (Direct) | View |
2021-02-17 Purchase | 2021-02-19 6:56 pm | Decibel Therapeutics Inc. | DBTX | Casdin Partners Master Fund L.P. 10% Owner | 575,000 | $18 | $10,350,000 | 1,121,421 (Indirect) | View |
2020-11-24 Purchase | 2020-11-27 5:23 pm | BIOLIFE SOLUTIONS INC | BLFS | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner | 1,600,000 | $22.5 | $36,000,000 | 7,440,107 (Direct) | View |
2020-07-01 Purchase | 2020-07-02 4:48 pm | BIOLIFE SOLUTIONS INC | BLFS | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner | 990,583 | $14.5 | $14,363,454 | 5,840,107 (Direct) | View |
2020-05-22 Purchase | 2020-05-26 1:54 pm | BIOLIFE SOLUTIONS INC | BLFS | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner | 476,191 | $10.5 | $5,000,006 | 4,849,524 (Direct) | View |
2020-05-14 Purchase | 2020-05-18 4:47 pm | BIOLIFE SOLUTIONS INC | BLFS | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner | 1,904,762 | $10.5 | $20,000,001 | 4,373,333 (Direct) | View |
2019-11-19 Purchase | 2019-11-21 12:52 pm | BIOLIFE SOLUTIONS INC | BLFS | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner | 40,000 | $15.41 | $616,536 | 2,468,571 (Direct) | View |
2019-07-22 Purchase | 2019-07-22 4:31 pm | Fulcrum Therapeutics Inc. | FULC | Casdin Capital LLC Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Eli 10% Owner | 140,000 | $15.84 | $2,217,495 | 604,285 (Indirect) | View |
2018-07-23 Purchase | 2018-07-23 8:12 pm | CONSTELLATION PHARMACEUTICALS INC | CNST | Casdin Capital LLC Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Eli Casdin Venture Opportunities Fund L.P. CASDIN VENTURE OPPORTUNITIES FUND GP LLC 10% Owner | 266,667 | $15 | $4,000,005 | 158,960 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-04-04 Option Award | 2022-04-06 5:54 pm | N/A N/A | STANDARD BIOTOOLS Inc | LAB | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Private Growth Equity Fund II L.P. Casdin Private Growth Equity Fund II GP LLC Director 10% Owner | 127,780 | $0 | 127,780 (Direct) | View |
2021-09-01 Other | 2021-11-03 1:10 pm | N/A N/A | BIOLIFE SOLUTIONS INC | BLFS | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner | 126,185 | $0 | 7,692,477 (Direct) | View |
2021-08-03 Conversion | 2021-08-04 6:33 pm | N/A N/A | Tenaya Therapeutics Inc. | TNYA | Casdin Partners Master Fund L.P. Casdin Private Growth Equity Fund L.P. Casdin Capital LLC CASDIN PRIVATE GROWTH EQUITY FUND GP LLC 10% Owner | 5,111,667 | $0 | 361,969 (Indirect) | View |
2021-07-29 Ownership | 2021-07-30 2:56 pm | N/A N/A | MAXCYTE Inc | MXCT | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner | 0 | $0 | 12,171,334 (Direct) | View |
2021-07-29 Ownership | 2021-07-29 7:28 pm | N/A N/A | Tenaya Therapeutics Inc. | TNYA | Casdin Partners Master Fund L.P. Casdin Capital LLC CASDIN PRIVATE GROWTH EQUITY FUND GP LLC Casdin Private Growth Equity Fund L.P. 10% Owner | 0 | $0 | 2,736,818 (Indirect) | View |
2021-07-26 Conversion | 2021-07-28 4:33 pm | N/A N/A | Absci Corp | ABSI | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Private Growth Equity Fund L.P. CASDIN PRIVATE GROWTH EQUITY FUND GP LLC Director | 31,995,620 | $0 | 7,718,593 (Direct) | View |
2021-07-21 Ownership | 2021-07-21 8:53 pm | N/A N/A | Absci Corp | ABSI | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Private Growth Equity Fund L.P. CASDIN PRIVATE GROWTH EQUITY FUND GP LLC Director 10% Owner | 0 | $0 | 6,156,093 (Direct) | View |
2021-06-21 Conversion | 2021-06-22 5:12 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Casdin Partners Master Fund L.P. 10% Owner | 13,517,885 | $0 | 2,417,596 (Direct) | View |
2021-06-16 Ownership | 2021-06-16 7:27 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Casdin Partners Master Fund L.P. 10% Owner | 0 | $0 | 1,317,596 (Direct) | View |
2021-02-17 Conversion | 2021-02-19 6:56 pm | N/A N/A | Decibel Therapeutics Inc. | DBTX | Casdin Partners Master Fund L.P. 10% Owner | 3,442,453 | $0 | 1,121,421 (Indirect) | View |
2021-02-11 Ownership | 2021-02-11 9:29 pm | N/A N/A | Decibel Therapeutics Inc. | DBTX | Casdin Partners Master Fund L.P. 10% Owner | 0 | $0 | 546,421 (Indirect) | View |
2019-07-22 Conversion | 2019-07-22 4:31 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Casdin Capital LLC Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Eli 10% Owner | 3,714,285 | $0 | 604,285 (Indirect) | View |
2019-07-17 Ownership | 2019-07-17 7:40 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Casdin Capital LLC Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Eli 10% Owner | 0 | $0 | 464,285 (Indirect) | View |
2018-08-10 Ownership | 2018-08-15 4:58 pm | N/A N/A | BIOLIFE SOLUTIONS INC | BLFS | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner | 0 | $0 | 2,428,571 (Direct) | View |
2018-07-23 Conversion | 2018-07-23 8:12 pm | N/A N/A | CONSTELLATION PHARMACEUTICALS INC | CNST | Casdin Capital LLC Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Eli Casdin Venture Opportunities Fund L.P. CASDIN VENTURE OPPORTUNITIES FUND GP LLC 10% Owner | 5,680,511 | $0 | 158,960 (Indirect) | View |
2018-07-18 Ownership | 2018-07-18 5:38 pm | N/A N/A | CONSTELLATION PHARMACEUTICALS INC | CNST | Casdin Capital LLC Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Eli Casdin Venture Opportunities Fund L.P. CASDIN VENTURE OPPORTUNITIES FUND GP LLC 10% Owner | 0 | $0 | 504,743 (Indirect) | View |